CAS: 1365970-03-1 - Glecaprevir
- Synonyms:
- Abt-493
- (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-N-((1R,2R)-2-(difluoromethyl)-1-(((1-methylcyclopropyl)sulfonyl)carbamoyl)cyclopropyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35
Glecaprevir
CAS:1365970-03-1
Formula:
C38H46F4N6O9S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
838.8653
Ref: AN-AG01EOG9
5mg | 56.00 € | |
10mg | 72.00 € | |
25mg | 116.00 € | |
50mg | 194.00 € | |
100mg | 236.00 € | |
250mg | 622.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
Ref: 4Z-G-194003
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Monday 3 Jun 2024
Ref: 4Z-G-194001
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Monday 3 Jun 2024
Ref: 4Z-G-194002
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Monday 3 Jun 2024
Glecaprevir
CAS:1365970-03-1
Glecaprevir (ABT-493) is an HCV NS3/4A protease inhibitor, (IC50s: 3.5-11.3 nM).
Formula:
C38H46F4N6O9S
Purity:
99.86%
Color and Shape:
Solid
Molecular weight:
838.87
Ref: TM-T5126
2mg | 38.00 € | |
5mg | 56.00 € | |
10mg | 83.00 € | |
25mg | 153.00 € | |
50mg | 270.00 € | |
100mg | 419.00 € | |
1ml*10 (DMSO) | 79.00 € |
Estimated delivery in United States, on Monday 3 Jun 2024
Glecaprevir
CAS:1365970-03-1
Applications Glecaprevir is an antiviral drug used in the treatment of patients with hepatitis C …
Formula:
C38H46F4N6O9S
Color and Shape:
Neat
Molecular weight:
838.86
Ref: TR-G407015
5mg | 416.00 € | |
10mg | 661.00 € | |
50mg | 1,276.00 € |
Estimated delivery in United States, on Tuesday 4 Jun 2024
Glecaprevir-13C,D3
Controlled ProductCAS:1365970-03-1
Formula:
CC37D3H43F4N6O9S
Color and Shape:
Neat
Molecular weight:
842.876
Ref: TR-G407016
10mg | 46,266.00 € |
Estimated delivery in United States, on Friday 5 Jul 2024